HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Binding and transport of melanoma-specific antigenic peptides by the transporter associated with antigen processing.

Abstract
To gain insight into how tumor antigens are generated and presented, a panel of peptides corresponding to melanoma-specific T cell epitopes were tested for their transport capacity by the transporter associated with antigen processing (TAP). The melanoma epitopes exhibited differential capacities to be transported by TAP in streptolysin O-permeabilized cells, as well as differential competition for peptide binding to TAP. The data indicate that some melanoma-specific epitopes are good substrates for TAP, while others are poor substrates for TAP. One of the epitopes, derived from tyrosinase, was transported into the endoplasmic reticulum (ER), in spite of being a poor competitor for reporter peptide transport and for peptide binding. These results suggest that the melanoma antigens follow distinct pathways for presentation, along the MHC class I pathway.
AuthorsS A Chang, V G Lacaille, D S Guttoh, M J Androlewicz
JournalMolecular immunology (Mol Immunol) Vol. 33 Issue 15 Pg. 1165-9 (Oct 1996) ISSN: 0161-5890 [Print] England
PMID9070664 (Publication Type: Journal Article)
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B, Member 3
  • ATP-Binding Cassette Transporters
  • Antigens, Neoplasm
  • Epitopes
  • Peptides
  • TAP2 protein, human
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 3
  • ATP-Binding Cassette Transporters (immunology)
  • Amino Acid Sequence
  • Antigen Presentation
  • Antigens, Neoplasm (metabolism)
  • Epitopes
  • Humans
  • Major Histocompatibility Complex (immunology)
  • Melanoma (immunology)
  • Peptides (chemistry)
  • Protein Binding

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: